178 related articles for article (PubMed ID: 3284990)
1. Cytoimmunologic monitoring in early and late acute cardiac rejection.
Fieguth HG; Haverich A; Schäfers HJ; Wahlers T; Herrmann G; Frimpong-Boateng K; Cremer J; Kemnitz J; Borst HG
J Heart Transplant; 1988; 7(2):95-101. PubMed ID: 3284990
[TBL] [Abstract][Full Text] [Related]
2. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients.
Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ
J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and dynamics of acute rejection after heterotopic heart transplantation.
Schüetz A; Kemkes BM; Breuer M; Brandl U; Engelhardt M; Kugler C; Manz C; Hatz R; Gokel JM; Hammer C
J Heart Lung Transplant; 1992; 11(2 Pt 1):289-99; discussion 299-300. PubMed ID: 1576135
[TBL] [Abstract][Full Text] [Related]
4. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
[TBL] [Abstract][Full Text] [Related]
5. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
[TBL] [Abstract][Full Text] [Related]
7. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
8. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
9. Cytoimmunologic monitoring after heart and heart-lung transplantation.
May RM; Cooper DK; Du Toit ED; Reichart B
J Heart Transplant; 1990; 9(2):133-5. PubMed ID: 2319372
[TBL] [Abstract][Full Text] [Related]
10. Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation.
Spratt P; Sivathasan C; Macdonald P; Keogh A; Chang V
J Heart Lung Transplant; 1991; 10(6):912-4. PubMed ID: 1756155
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
12. Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection.
Anderson JR; Hossein-Nia M; Brown PA; Corbishley C; Murday AJ; Holt DW
J Heart Lung Transplant; 1995; 14(4):666-70. PubMed ID: 7578173
[TBL] [Abstract][Full Text] [Related]
13. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
14. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
Loertscher R; Forbes RD; Halabi G; Lavery P; Quinn T
Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
[TBL] [Abstract][Full Text] [Related]
15. Cytoimmunologic monitoring and heart transplantation.
Hanson CA; Bolling SF; Stoolman LM; Schlegelmilch JA; Abrams GD; Miska PT; Deeb GM
J Heart Transplant; 1988; 7(6):424-9. PubMed ID: 3062148
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for acute allograft rejection after heart transplantation.
Carrier M; Russell DH; Cork RC; Wild J; Emery RW; Copeland JG
J Heart Transplant; 1990; 9(4):372-5. PubMed ID: 2398431
[TBL] [Abstract][Full Text] [Related]
17. Heart transplantation in Norway. Morphological monitoring of cardiac allograft rejection. A 3-year follow-up.
Foerster A; Simonsen S; Frøysaker T
APMIS; 1988 Jan; 96(1):14-24. PubMed ID: 3278719
[TBL] [Abstract][Full Text] [Related]
18. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
[TBL] [Abstract][Full Text] [Related]
19. Routine surveillance endomyocardial biopsy: late rejection after heart transplantation.
Heimansohn DA; Robison RJ; Paris JM; Matheny RG; Bogdon J; Shaar CJ
Ann Thorac Surg; 1997 Nov; 64(5):1231-6. PubMed ID: 9386684
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil transendothelial migration potential predicts rejection severity in human cardiac transplantation.
Healy DG; Watson RW; O'Keane C; Egan JJ; McCarthy JF; Hurley J; Fitzpatrick J; Wood AE
Eur J Cardiothorac Surg; 2006 May; 29(5):760-6. PubMed ID: 16616855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
